DTX-P7
DTX-P7 is a peptide-drug conjugate. DTX-P7, composed of Docetaxel (DTX, HY-B0011) and a heptapeptide (P7), induces unfolded protein response and subsequent apoptosis by degrading Hsp90[1].
Product Specifications
UNSPSC
12352209
Target
Apoptosis; Eukaryotic Initiation Factor (eIF) ; HSP; Peptide-Drug Conjugates (PDCs) ; PERK
Type
Peptides
Related Pathways
Antibody-drug Conjugate/ADC Related; Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dtx-p7.html
Smiles
O=C(OC(C)(C)C)N[C@H]([C@@H](OC(CCC(N[C@@H](CC(C)C)C(N1[C@H](C(N[C@H](C(N[C@@H]([C@H](O)C)C(N2CCC[C@H]2C(N[C@@H](CC(C)C)C(N3CCC[C@H]3C(O)=O)=O)=O)=O)=O)CC(C)C)=O)CCC1)=O)=O)=O)C(O[C@@H]4C(C)=C([C@@H](O)C([C@@]5(C)[C@]([C@@](CO6)(OC(C)=O)[C@@]6([H])C[C@@H]5O)([H])[C@@H]7OC(C8=CC=CC=C8)=O)=O)C(C)(C)[C@@]7(O)C4)=O)C9=CC=CC=C9
Molecular Formula
C84H118N8O25
Molecular Weight
1639.87
References & Citations
[1]Yao Jiang, et al. DTX-P7, a peptide-drug conjugate, is highly effective for non-small cell lung cancer. J Hematol Oncol. 2022 Jun 3;15 (1) :73.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402848-100 1x 100 µL
Fibronectin (Fn-3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880177-100 1x 100 µL
CD50 (ICAM-3) (101-1D2), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940149-100 1x 100 µL
CD106 / VCAM1 (1.4C3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
